J Korean Neuropsychiatr Assoc.  2015 Feb;54(1):127-131. 10.4306/jknpa.2015.54.1.127.

A Case of Clinical Application of Covert Sensitization in a Patient with Kleptomania

Affiliations
  • 1Department of Psychiatry, Chonbuk National University Medical School, Jeonju, Korea. yangjc@jbnu.ac.kr
  • 2Department of Psychiatry, Jeonbuk Provincial Maeumsarang Hospital, Wanju, Korea.
  • 3Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital, Jeonju, Korea.

Abstract

Kleptomania is a well-known impulse-control disorder. Although it is a rare disease, it exerts a greater influence on the social and economic. There are a variety of treatments for kleptomania, however case reports of its specific treatment techniques are extremely rare. In this case, covert sensitization was applied to a 44-year-old hospitalized patient with kleptomania, which can facilitate a specific treatment method through case presentation.

Keyword

Kleptomania; Covert sensitization; Cognitive behavior therapy

MeSH Terms

Adult
Cognitive Therapy
Humans
Disruptive, Impulse Control, and Conduct Disorders*
Rare Diseases

Reference

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association;2013.
2. Goldman MJ. Kleptomania: making sense of the nonsensical. Am J Psychiatry. 1991; 148:986–996.
Article
3. Grant JE, Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Compr Psychiatry. 2002; 43:378–384.
Article
4. Koran LM, Aboujaoude EN, Gamel NN. Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J Clin Psychiatry. 2007; 68:422–427.
5. Grant JE, Kim SW, Odlaug BL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009; 65:600–606.
Article
6. Grant JE. Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci. 2006; 43:81–87.
7. Grant JE, Potenza MN. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004; 16:27–34.
Article
8. Grant JE, Odlaug BL. [Kleptomania: clinical characteristics and treatment]. Rev Bras Psiquiatr. 2008; 30:Supple 1. S11–S15.
9. Grant JE, Odlaug BL, Davis AA, Kim SW. Legal consequences of kleptomania. Psychiatr Q. 2009; 80:251–259.
Article
10. Presta S, Marazziti D, Dell'Osso L, Pfanner C, Pallanti S, Cassano GB. Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry. 2002; 43:7–12.
Article
11. Fishbain DA. Kleptomania as risk-taking behavior in response to depression. Am J Psychother. 1987; 41:598–603.
Article
12. McElroy SL, Pope HG Jr, Hudson JI, Keck PE Jr, White KL. Kleptomania: a report of 20 cases. Am J Psychiatry. 1991; 148:652–657.
Article
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr